Analyzing AI's critical role in equitable screening, enhancing fairness, physician collaboration, and outcomes in lung cancer detection.
Explore how AI technologies are reshaping the future of liver disease detection, management, and patient care.
A deeper look at the relationship between AI and lung cancer screening—from financial and clinical efficiency to patient engagement.
Explore AI's promise in early lung cancer detection through insights from experts at Lucem Health and Medial EarlySign, addressing challenges and strategies.
Learn how you can use Reveal for Stroke to take 100,000 screening ECGs and identify nearly 230 higher-risk AFib-related stroke patients.
Learn how Reveal for Stroke can identify previously undiagnosed AFib and help providers understand which patients have higher stroke-risk.
Going from 10,000 patients to about 300 – see how Reveal for Lower GI helps you more efficiently target patients that are at higher statistical risk for colorectal cancer and other lower GI disorders.
Reveal for Lower GI Overview Video: Target patients at higher statistical risk of colorectal cancer (CRC) and other lower GI disorders.
Watch our Lucem Health Reveal Overview Video to better understand how you can use the power of clinical AI to reveal hidden patient risks.
Reveal for Lung Cancer analyzes existing EHR data to identify patients who show a higher statistical risk of certain respiratory illnesses, including cancers of the lung or trachea.
Lucem Health helps healthcare providers accelerate disease detection and treatment using practical, responsible AI—so they can improve patients’ lives and increase the clinical and financial yield from today’s scarce care delivery resources.
Navigation
Navigation
Solutions
Early Disease Detection
Clinical Decision Support